Chemoinformaics analysis of n-nonadecanyl-n-docos-11-enoate
Molecular Weight | 605.089 | nRot | 37 |
Heavy Atom Molecular Weight | 524.449 | nRig | 2 |
Exact Molecular Weight | 604.616 | nRing | 0 |
Solubility: LogS | -8.375 | nHRing | 0 |
Solubility: LogP | 16.099 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 123 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 43 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 80 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 41 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 123.417 |
nHD | 0 | BPOL | 82.8606 |
QED | 0.04 |
Synth | 2.318 |
Natural Product Likeliness | 0.334 |
NR-PPAR-gamma | 0.022 |
Lipinski | Rejected |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.001 |
HIA | 0.006 |
CACO-2 | -5.415 |
MDCK | 0.00000163 |
BBB | 0 |
PPB | 1.06215 |
VDSS | 5.811 |
FU | 0.00546371 |
CYP1A2-inh | 0.016 |
CYP1A2-sub | 0.091 |
CYP2c19-inh | 0.074 |
CYP2c19-sub | 0.037 |
CYP2c9-inh | 0.009 |
CYP2c9-sub | 0.983 |
CYP2d6-inh | 0.009 |
CYP2d6-sub | 0.006 |
CYP3a4-inh | 0.119 |
CYP3a4-sub | 0.005 |
CL | 4.531 |
T12 | 0.004 |
hERG | 0.416 |
Ames | 0.004 |
ROA | 0.003 |
SkinSen | 0.992 |
Carcinogencity | 0.017 |
EI | 0.912 |
Respiratory | 0.142 |
NR-Aromatase | 0.058 |
Antiviral | No |
Prediction | 0.547642 |